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Abstract
Background: Diagnosis of influenza in older adults may be complicated by atypical presentations or when
patients present with complications of an underlying illness. We aimed to identify clinical characteristics
and epidemiological factors associated with influenza among community-dwelling adults aged ≥60 years
presenting to emergency departments.
Methods: We identified patients with influenza-compatible chief complaints presenting to emergency
departments of six acute care hospitals in Ontario, Canada during the 2011/12 and 2012/13 influenza seasons.
Clinical characteristics, medical history and demographics were collected by patient interview, chart review
and by contacting vaccine providers. Nasopharyngeal swabs were tested for influenza using polymerase chain
reaction. We modeled predictors of influenza using multivariable logistic regression models that compared
individuals with and without influenza.
Results: Of 1318 participants, 151 (11 %) had influenza (98 A/H3N2, 12 A/H1N1, 4 A [not sub-typed], 37 B).
In the multivariable model, clinical symptoms associated with influenza were cough (OR 6.4, 95 % CI 3.2, 13.0),
feverishness and/or triage temperature ≥37.2 °C (OR 3.0, 95 % CI 2.0, 4.7), 2–5 days from symptom onset to
the emergency department visit (OR 2.2, 95 % CI 1.5, 3.2), and wheezing (OR 2.1, 95 % CI 1.3, 3.3). The effect
of cough on influenza increased with older age. Epidemiological factors associated with increased odds for
influenza included weeks when ≥10 % influenza tests from provincial laboratories were positive (OR 5.1, 95 % CI 1.2,
21.7) and exposure to a person with influenza-like illness (OR 1.9, 95 % CI 1.3, 2.8). Among participants with influenza,
only 47 (31 %) met the U.S. Centers for Disease Control and Prevention criteria for influenza-like illness
(temperature ≥37.8 °C and cough and/or sore throat).
Conclusions: As in younger adults, cough and feverishness are the two symptoms most predictive of
influenza in the elderly. Current influenza-like illness definitions did not adequately capture influenza in
older adults.
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Background
Accurate and timely diagnosis of influenza is especially
important for older adults who are at higher risk for
severe complications and for whom influenza vaccines
are less effective [1–3]. Laboratory testing with polyme-
rase chain reaction (PCR) is not always available, and
most other tests are of relatively low sensitivity and/or
may not yield results in a timely manner [4]. Diagnosis
based on signs and symptoms is challenging because
influenza symptoms are difficult to distinguish from
those of other viral respiratory tract infections (e.g.,
respiratory syncytial virus, rhinovirus) [2, 5], and because
influenza may present as a complication of an underlying
illness (e.g., exacerbation of chronic obstructive pulmo-
nary disease) rather than as a primary illness [2].
Current evidence on the predictors of influenza in the
elderly is limited. Previous studies have identified feve-
rishness, cough, myalgia, pain on respiration, headache,
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sore throat and rigor/chills as clinical symptoms associ-
ated with influenza [6–12]. As in younger adults, cough
and fever have the highest positive predictive value (PPV)
[13]. However, past efforts to identify useful symptom
clusters have not been able to determine a combination
that discriminate adequately between influenza and other
illnesses [6, 8, 11, 12, 14]. The aim of this study was to
identify clinical characteristics and/or epidemiological fac-
tors associated with influenza among community-dwelling
adults older adults presenting to emergency departments
(EDs).
Methods
Study design and setting
We prospectively recruited community-dwelling older
adults age ≥60 years presenting to the EDs of six acute
care hospitals in urban and suburban areas of south-
central Ontario, Canada. These EDs had a median of
175 visits per day (range 160–350). Patients or their
substitute decision-makers were approached for consent,
nasopharyngeal swabs were collected, and, whenever
possible, interviews were conducted while they were
in the ED.
Participant enrollment
Participant enrollment occurred during weeks when the
proportion of specimens submitted to Ontario laborato-
ries testing positive for influenza was greater than 5 %
for the 2011/12 and 2012/13 seasons (Fig. 1). Study
personnel screened and enrolled patients from each site
during five, 8-h shifts per week. The shifts were sche-
duled to sample patients in each ED on all seven days of
the week for 24 h of the day. Study eligible patients who
had most recently arrived were approached first by the
research assistant to avoid bias introduced by recruiting
patients with longer ED stays. Study approval was
obtained from all participating hospital research ethics
boards (REBs).
Eligible patients had chief complaints of cardiac, respira-
tory or cerebrovascular events, systemic symptoms (fever,
weakness) or altered level of consciousness. Patients with
chief complaints related to trauma, mental disorders,
post-operation complications and/or urogenital problems
were not eligible. For other chief complaints, patients were
included if their triage record indicated any of the follow-
ing symptoms or conditions: respiratory symptoms, triage
temperature ≥37.5 °C, feverishness, malaise, or general
weakness. Residents of long-term care homes or other
group settings (e.g., detention centers) and patients who
had been enrolled in the study within the previous 14 days
were not eligible.
Data collection
Recruiters interviewed participants to determine symp-
toms, lifestyle, healthcare use, history of pneumococcal
vaccination, and influenza vaccination in the previous
five years, medical care/consultation during current illness
episode, and Clinical Frailty Scale items [15]. Demo-
graphic, medical history, and symptom information were
also collected by chart review. The participant’s vaccine
provider and/or family physician was contacted to obtain
influenza vaccination history (for the present and previous
season), pneumococcal vaccination history and infor-
mation on prior visits related to the current episode of
illness. Vaccine providers were re-contacted to confirm
vaccination information if provider and patient-reported
status were discrepant. If the discrepancy could not
be resolved, the ‘yes’ response from either source was
accepted. Similarly, for discrepancies between self-reported
Fig. 1 Participants with and without influenza and the percentage of specimens testing positive for influenza submitted to Ontario laboratories
by epidemiological week, 2011–2012 and 2012–2013 seasons
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and chart data for symptoms or medical history, a ‘yes’ from
either source was taken as the final response.
The outcome of interest was laboratory-confirmed
influenza infection. A nasopharyngeal swab collected on
date of enrolment was tested for influenza by reverse
transcription PCR (RT-PCR) at a single study laboratory
within 24 h of collection using bioMérieux easyMAG
with RealStar® influenza RT-PCR (Altona Diagnostics) in
2011/12 and Simplexa™ Flu A/B & RSV Direct RT-PCR
(Focus Diagnostics) in 2012/13.
A priori hypothesized predictors of influenza infection
were symptoms (cough, fever, acute confusion, sore throat,
chills, headache, myalgia, rhinorrhea, wheezing), acute
onset of symptoms, influenza vaccination status, children
aged ≤16 years in the household, regular contact with
children outside the household, exposure to person(s)
with influenza-like illness (ILI), recent use of public
transit, and the level of influenza activity in the commu-
nity. We also hypothesized that the association between
symptoms and influenza infection would vary across
age, presence of underlying illnesses, use of medications
for the current episode of illness, deprivation score, and
level of frailty.
Predictor definitions
We chose definitions of predictors to maximize sensiti-
vity and best discriminate between those with and with-
out influenza, with preference given to variables being
readily available in ED settings. We assessed self-reported
and chart-recorded severity (mild, moderate or severe)
of clinical symptoms as well.
The definition of cough was a composite of self-reported
and/or chart-recorded data. Participants were recorded as
having cough if it was reported during the interview as a
symptom prior to the ED visit or if cough was recorded in
the medical chart. Fever was defined as self-reported fever-
ishness and/or having a triage-recorded temperature
≥37.2 °C [13]. All participants were asked if they felt
feverishness during their current episode of illness. Acute
onset of symptoms was defined as being sudden (i.e., woke
up feeling miserable or were unable to do regular activities
within a few hours) versus gradual development (i.e.,
symptoms worsened over several days). Time from symp-
tom onset to ED visit was calculated as the number of
days between participant-reported day of onset and
presentation to the ED.
A participant was defined as having received the influ-
enza vaccine if it was received in the current season and
≥14 days before symptom onset. Participants' chronic
conditions were abstracted from medical records and
medication history was collected by interview and medical
chart review.
Participants were asked if they lived with children
(≤16 years), and whether they had regular contact (≥4 h
per day and for ≥4 days per week) with other children
outside the household. Recent use of public transporta-
tion included riding a bus, subway, train, or streetcar
within four days of symptom onset. Exposure to a person
with an ILI was defined as being within arm’s length for
≥2 min to someone the participant recognized as having
symptoms of an acute respiratory illness (i.e., had cough,
stuffy or runny nose, hoarseness or a sore throat) within
7 days of symptom onset.
Influenza activity in the community was defined as the
proportion of specimens positive for influenza submitted
to laboratories in south-central Ontario during the past
week. Neighborhood-based material and social deprivation
indices were determined by matching participants’ postal
codes with the Canadian Deprivation Index database [16].
The index is divided into 5 quintiles with ‘1’ being the
most privileged and ‘5’ representing the most deprived.
Ethnicity was self-reported by participants. Frailty was
defined as having a score of ≥5 on the Clinical Frailty
Scale (maximum 9 points), as scored by a trained
research assistant [15], where the participant required at
least some assistance with daily activities [17].
Statistical analyses
We compared the characteristics of individuals having
laboratory-confirmed influenza with those who tested
negative. Chi-square and Fisher’s exact tests were applied
to assess differences among group proportions. Medians
were compared using Wilcoxon rank-sum tests. Reported
p-values are two-sided with a value <0.05 considered
to be statistically significant. No correction was made
for multiple testing. Odds ratios (OR) and 95 % confi-
dence intervals (CI) were estimated using logistic regres-
sion. Hypothesized predictors significant at p <0.2 in
the bivariate analysis were included in the initial logistic
regression model [18]. The full model was reduced by
sequentially removing predictors that did not significantly
improve the fit of the model as determined by the Like-
lihood Ratio Test [18]. Hosmer-Lemeshow Goodness-of-
Fit Test and residuals plots were used to assess model fit.
Variance inflation factors (VIF > 10) were used to assess
for collinearity between predictors. No imputation was
done for missing data. In the multivariable analysis, partic-
ipants with missing data on included predictors were ex-
cluded. The final model was adjusted for hospital site and
had at least ten events per predictor in the model.
Statistical interaction terms, determined a priori, were
entered as cross-product terms in a logistic regression
model. If significant in the crude analysis, the interaction
term was added to the final model and assessed for
significance [19]. To interpret effect modification, the
odds ratio was calculated for one predictor on the out-
come over the levels of another predictor. Vaccine effec-
tiveness was calculated as (1 - OR) X 100.
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To explore potential differences between influenza types
(A & B), we compared each type to influenza-negative
participants. We used SAS version 9.3 (SAS Institute,
Cary, NC, USA) for all analyses.
Results
Participants
Among eligible patients, 64 % were approached by a
research assistant and, of those approached, 65 % con-
sented to participate in the study (Fig. 2). In total, 1318
people were enrolled: 606 (46 %) during the 2011/12 and
712 (54 %) during the 2012/13 influenza seasons. Median
participant age was 76.4 years (interquartile range:
68.5–84.2 years), and 656 (50 %) were female. The
majority (n = 868, 66 %) had been immunized against
influenza in the current season, and 61 % reported one or
more underlying chronic diseases. Overall, 151 parti-
cipants (11 %) tested positive for influenza (98 A/H3N2,
12 A/H1N1, 4 A [not sub-typed], 37 B). A greater propor-
tion of individuals had influenza during the 2012/13
season (108/712, 15 %) compared to the 2011/12 season
(43/606, 7 %; p < 0.001). The proportion of participants
with influenza varied across hospital sites ranging from
6 % to 23 % (median 18 %).
Participants with influenza and those without influenza
did not differ by age, sex, vaccination status, or underlying
chronic disease status (Table 1). However, those with
influenza were significantly more likely to live in neigh-
borhoods with high material deprivation scores, less likely
to be Caucasian, and more likely to have been prescribed
antibiotics and used symptom relief medications prior to
ED arrival. Only two participants reported the use of an
antiviral drug prior to their ED visit.
Among those with influenza, 31 % presented with
symptoms that matched the U.S. Centers for Disease
Control and Prevention definition for ILI (temperature
≥37.8 °C and cough and/or sore throat) [20], with a
specificity of 92 %, sensitivity of 31 %, PPV of 34 %
and negative predictive value (NPV) of 91 %. The Public
Health Agency of Canada definition for ILI (acute onset of
symptoms, fever and cough with sore throat, arthralgia,
myalgia or prostration) [21] captured 32 % of the influenza
positive participants with a specificity of 91 %, sensitivity
of 32 %, PPV of 31 % and NPV of 91 %.
Fig. 2 Flow diagram of participant enrollment
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Predictors of influenza
Cough as indicated by medical chart review had lower
sensitivity (128/151, 85 %) compared with self-report
(139/151, 92 %). A composite variable that included
self-reported and/or chart-recorded cough achieved the
highest sensitivity (142/151, 94 %) with 44 % specificity,
18 % PPV and 98 % NPV. Cough was the most common
(94 %) respiratory symptom among those with influenza
(Table 1). In the bivariate analysis, all three definitions
of coughing were associated with influenza: cough as
indicated by chart review (OR 8.9, 95 % CI 5.6, 14.1),
self-reported cough (OR 11.1, 95 % CI 6.1, 20.2) and
the composite variable (OR 12.6, 95 % CI 6.4, 24.9).
Participants with influenza had a higher median triage
temperature than those without influenza (37.3 °C versus
36.7 °C, p < 0.001). In this sample, 32 % of those with
influenza had a triage temperature ≥37.8 °C (specificity
75 %); a lower temperature cut-off of 37.2 °C captured
55 % of those with influenza (specificity 79 %). A
composite variable of self-reported feverishness and/or
measured temperature (≥37.2 °C) had the highest sensi-
tivity (76 %), with 60 % specificity, 20 % PPV and 95 %
NPV.
Participants with influenza were more likely to report
one or more of: wheezing, sore throat, stuffy/runny nose,
shortness of breath, or sneezing (Table 1). They were
also significantly more likely to report more systemic
symptoms (headache, myalgia, chills, weakness, fatigue,
or loss of appetite) (p < 0.001).
Table 1 Symptoms and characteristics of participants aged
≥60 years with and without influenza presenting to emergency
departments, Ontario, Canada, 2011/12 and 2012/13
Participant characteristics/
symptomsa
No Influenza Influenza p-value
n = 1167 (%) n = 151 (%)





Female sex 578 (50) 78 (52) .62
Used public transportation
≤4 days before onset
160 (14) 23 (15) .62
Children (≤16 years)
in household
98 (8) 17 (11) .26
Works with children 14 (1) 5 (3) .06
Exposed to person with ILI
≤7 days before onset
275 (24) 64 (42) <.001
Material deprivation index†,
Median
3 (IQR 1–4) 3 (IQR 2–5) .001
White/Caucasian 895 (78) 105 (70) .03
Influenza vaccine, current
season
768 (66) 100 (68) .75
Pulmonary /cardiac disease
or immunosuppressed
709 (61) 93 (62) .84
Frail (≥5 on Clinical Frailty Score) 309 (27) 36 (24) .35
Enrolment season:
2011/12 563 (93) 43 (7) <.001
2012/13 604 (85) 108 (15)
Enrolled week when ≥10 %
of influenza tests positive
1057 (91) 149 (99) <.001
Healthcare use prior to ED arrival
Prior consultation with health
practitioner
465 (40) 66 (44) .34
Antibiotics prescribed 187 (16) 40 (26) .002
Antipyretics taken 512 (44) 68 (45) .79
Other general symptom
relief medications taken
85 (7) 24 (16) .001
Presenting symptoms
Cough (self-report and/or chart) 649 (56) 142 (94) <.001
Wheezing (chart) 90 (8) 35 (23) <.001
Sore throat 244 (21) 60 (40) <.001
Stuffy/runny nose 353 (30) 88 (58) <.001
Sneezing 274 (24) 50 (33) .01
Shortness of breath 693 (59) 98 (65) .19
Any one or more of: sore
throat, runny/stuffy nose
or sneezing
522 (45) 111 (74) <.001
Feverishness and/or triage
temp ≥37.2 °C
463 (40) 115 (76) <.001
Headache 419 (36) 71 (47) .01
Myalgia 357 (31) 71 (47) <.001
Chills (self-report and/or chart) 172 (15) 57 (38) <.001
Weakness 873 (75) 125 (83) .03
Table 1 Symptoms and characteristics of participants aged
≥60 years with and without influenza presenting to emergency
departments, Ontario, Canada, 2011/12 and 2012/13 (Continued)
Fatigue 906 (78) 138 (91) <.001
Loss of appetite 603 (52) 102 (68) <.001
Median number of systemic
symptoms (headache,
myalgia, chills, weakness,
fatigue, or loss of appetite)
2 (IQR 2–3) 3 (IQR 2–4) <.001
Confused
(self-report and/or chart)
257 (22) 46 (30) .02
Time from symptom onset
to ED triage:
0–1 day 451 (39) 25 (17) <.001
2–5 days 320 (27) 81 (54)
≥ 6 days 393 (34) 43 (29)
Acute onset of symptoms‡ 586 (50) 70 (47) .33
IQR Interquartile range, ED Emergency department, ILI influenza-like illness
aSymptoms and characteristics were based on self-reported data unless
indicated otherwise; The proportion of participants with missing data for any
given predictor did not exceed 3 %
†Material deprivation index ranks from 1 (most privileged neighborhood) to 5
quintiles (most deprived neighborhood)
‡Acute onset was self-defined as symptom development within a few hours ra-
ther than gradual worsening of symptoms ≥ 6 h
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Individuals with influenza were more likely to present
to the ED during weeks with a higher proportion of
lab specimens yielding influenza as compared to those
without influenza (median 29 % versus 21 %, p <0.001,
Fig. 1). To guide clinical decision-making, a threshold of
10 % was used to define seasonal influenza activity [22].
In the multivariable model (Table 2), the predictors
with the highest ORs for influenza were cough and
feverishness. Hospital site did not improve the fit of the
regression model (likelihood ratio test p = 0.12) but it
was included in the final model to control for possible
confounding on the association between predictors and
outcome [18].
The OR for the association between cough and influ-
enza infection was modified by age, with the effect of
cough being greater in older age groups (Table 3).
Among those who were not frail, confusion (as identified
by either patient interview or chart review) was associ-
ated with having influenza (adjusted OR 2.0, 95 % CI
1.2, 3.3; p-value for interaction term = 0.004); no associ-
ation was observed in frail individuals (adjusted OR 0.46,
95 % CI 0.18, 1.1). The effect of influenza vaccination
differed across the two study seasons (Breslow-Day test
for homogeneity p = 0.01). The estimated vaccine effect-
iveness (adjusted for predictors and interaction terms in
the final model) was 47 % (95 % CI -8 %, 74 %) in 2011/12
and -51 % (95 % CI -154 %, 11 %) in 2012/13, a year with
high H3N2 activity.
Almost all influenza B cases (89 %) were recruited in the
first season and the majority of influenza A (91 %) cases
were from season two. In an exploratory bivariate analysis,
cough, wheezing, feverishness, any upper respiratory





n = 1313 p-value n = 1313 p-value
Presenting symptoms‡
Cough (self-report and/or chart) 12.4 (6.3, 24.6) <.001 6.4 (3.2, 13.0) <.001
Wheeze (chart) 3.7 (2.4, 5.7) <.001 2.1 (1.3, 3.3) .003
Any one or more of: sore throat, runny/stuffy nose, or sneezing 3.5 (2.4, 5.1) <.001 –
Feverishness and/or triage temperature ≥37.2 °C 4.8 (3.2, 7.1) <.001 3.0 (2.0, 4.7) <.001
Number of systemic symptom(s)₴ 1.5 (1.3, 1.7) <.001 –
Confused (self-report and/or chart) 1.6 (1.1, 2.3) .02 –
Time to ED from symptom onset (2–5 days)¶ 3.1 (2.2, 4.5) <.001 2.2 (1.5, 3.2) <.001
Medical history
Influenza vaccine, current season 1.1 (0.8, 1.6) .59 –
Antibiotics prescribed/taken prior to visit 1.9 (1.3, 2.8) .001 –
General symptom relief medications prior to visit 2.4 (1.5, 4.0) <.001 –
Frail (≥5 on Clinical Frailty Score) 0.78 (0.52, 1.2) .24 –
Other factors
Age, per 10 year increaseǁ 1. 1 (0.9, 1.3) .51 1.2 (1.0, 1.5) .03
Children (<16 years) in household 1.4 (0.8, 2.4) .21 –
Recent transportation use 1.1 (0.7, 1.8) .58 –
Exposed to person with ILI ≤7 days before onset 2.5 (1.7, 3.5) <.001 1.9 (1.3, 2.8) .002
Material deprivation indexb 1.2 (1.1, 1.4) .002 –
Caucasian/White 0.67 (0.46, 0.98) .04 –
Enrolled week when ≥10 % of influenza tests positive 7.7 (1.9, 31.3) .005 5.1 (1.2, 21.7) .03
OR Odds ratio, CI Confidence interval, ED emergency department, ILI influenza-like illness
aParticipants with missing data on included predictors were excluded from the analysis. The proportion of participants with missing data for any given predictor
did not exceed 3 %
bMaterial deprivation index ranks from 1 (most privileged neighborhood) to 5 quintiles (most deprived neighborhood). The index is modeled as a continuous
variable with one unit increase equivalent to an increase in quintile
†Adjusted model also includes hospital site
‡Symptoms were based on self-reported data unless indicated otherwise
₴Systemic symptoms were headache, myalgia, chills, weakness, fatigue, and loss of appetite. Predictor modeled as a continuous variable with one unit increase
per addition of one symptom
¶Reference group: 0–1 days and >5 days for time to ED from symptom onset
ǁAge was modeled as a continuous variable per 10 years increase
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symptoms and chills were more prevalent among partici-
pants with influenza A as compared to those with influ-
enza B. In our sample, predictors of influenza type was
confounded by season of enrolment, as participants in
season one were more likely to be hospitalized com-
pared to those recruited in season two (70 % versus
50 %, p = 0.02).
Discussion
In this prospective cohort study of community-dwelling
older adults aged ≥60 years who attended an ED, we found
that symptoms of cough, feverishness, and wheezing
were independently associated with having influenza. We
also identified independent epidemiological predictors:
influenza positivity in Ontario laboratory specimens of
≥10 %, recent exposure to person(s) with ILI, presenting
to the ED 2-5 days after symptom onset and advanced
age.
Most participants with influenza had cough, which has
also been commonly reported in other studies of older
adults seeking medical attention [9, 10, 12]. Cough was
one of the two strongest predictors of influenza in older
adults. Only one other study has identified cough to be a
predictor of influenza infection in older adults and with
a similar magnitude of effect [6]. In studies that reported
a null association [8–11], only participants with ILI were
selected, and, as a result, these studies had limited ability
to detect the discriminating effect of cough. Cough has
also been reported as a clinical predictor of influenza
among younger adults and within the same effect size
range [13, 23, 24].
In our sample, cough was only associated with influenza
among those at advanced ages. The effect of age on the
association between cough and influenza is likely related
to the combination of the decrease in cough strength with
advancing age, and the greater cough stimulus associated
with influenza [25].
As seen in previous studies [6–8, 11, 12], fever
(self-reported feverishness and/or measured temperature)
has been associated with having influenza among older
adults. Measured fever is a known predictor of influenza
in younger adults [13, 24] but with a higher temperature
threshold (≥37.8 °C). It is expected that older adults with
acute infections present with a lower febrile response as
compared with younger adults. Similarly, a previous study
on hospitalized patients aged ≥65 years found that the
temperature threshold ≥37.2 °C captured 78 % of influenza-
positive individuals [26] .
Participants with influenza in our sample were more
likely to present to the ED 2–5 days after symptom
onset. Similarly, in other studies of community-dwelling
adults, patients with influenza most commonly sought
healthcare 3–7 days after symptom onset [8, 27]. A
recent meta-analysis showed that early treatment (within
two days of symptom onset) with neuraminidase inhi-
bitors is associated with decreased mortality risk com-
pared to later treatment [28]. In our sample, 54 % of those
with influenza presented too late to receive such early
treatment. Improved outcomes for the majority of our
participants will require better prevention, a significant
change in patient behaviour, and/or treatment options
that are effective when started ≥48 h after symptoms
onset.
Confusion is a known predictor of acute infection in
older adults [29]. In our sample, confusion was only
associated with influenza in those who were non-frail,
and not among already frail older adults.
Historically, influenza A has been considered to cause
more severe disease as compared to influenza B [30].
More recent evidence has shown that influenza B is also
capable of causing severe outcomes [30, 31] and similar
clinical symptoms in adults [32]. We found no distin-
guishing symptoms between influenza types in older
adults. However, it should be noted that the power to
identify differences is limited by our relatively small
sample size.
Exposure to persons with ILI is a known risk factor
for infection as human-to-human transmission occurs
readily with influenza viruses [33]. Regular contact with
children was not a predictor of influenza in our study.
However, <10 % of our participants had household
exposure to any children, and <3 % had household expo-
sure to children ≤5 years of age. Exposure to children
may be a more important factor in populations with
different social structures than our study population.
As seen in previous studies, ILI definitions only identi-
fied a small proportion of older adults with disease [34].
Syndromic diagnosis of influenza among older adults
Table 3 Effect of cough on being influenza positive by age,
Ontario, Canada, 2011/12 and 2012/13
Age (years) Odds ratio for influenza when
cough is present (95 % CI)a
60 1.3 (0.4, 4.6)
65 2.2 (0.9, 5.7)
70 3.8 (1.8, 8.2)
75 6.7 (3.0, 14.9)
80 11.6 (4.1, 33.2)
85 20.1 (4.9, 81.9)
90 34.8 (5.8, 210.6)
CI Confidence interval
aOdds ratio was adjusted for all other predictors in the final model: hospital
site, wheezing, feverishness, confusion, frailty, time to triage from symptom
onset, exposure to person with influenza-like illness, influenza activity in the
community, product term of confusion and frailty, and product term of cough
and age. Cough was based on chart-review and self-report
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remains a challenge and delays timely identification of
disease in a healthcare setting where the virus can be
transmitted to staff and other patients.
Strengths of our study include the use of PCR testing
for influenza (for high sensitivity), prospective data
collection on a broad range of epidemiological and cli-
nical risk factors, and broad inclusion criteria designed
to minimize missed influenza patients associated with
selection bias.
There are also a number of limitations. Patients with
severe disease or more frail individuals may have been
more likely to refuse (e.g., decline because of fatigue) or
less likely to be approached for inclusion in the study
(e.g., patients requiring resuscitation). However, we inter-
viewed family members of those unable to answer when-
ever possible, and, among those approached, only 6 %
declined because they were too tired or unwell. We were
not able to consider the impact of vaccination in prior
years on presentation, as the data were often missing, and
could not be validated.
We are unable to explain differences in rates of influ-
enza between hospital sites; however, none of our study
findings changed when the analysis was limited to spe-
cific hospitals, or when hospital site was removed from
the multivariable model. To reduce interview time for ill
patients, we did not use detailed tools for the assessment
of confusion, which may have altered our findings. Be-
cause there is no appropriate method to account for
multiple testing in an exploratory study [35], results are
presented without multiplicity adjustments and maybe
therefore be prone to Type I error. Our study is limited
to two influenza seasons in one geographic area and to
individuals presenting to EDs.
In our sample, exposures differed among those who
presented to the ED as their first healthcare contact
compared to those who consulted with other healthcare
providers prior to their ED visit. Patients presenting to
EDs may be different in the severity of illness or other
characteristics to those presenting at other types of set-
tings (e.g., primary care, walk-in clinics). The exposures
to influenza and care-seeking behavior of older adults
are likely to vary between populations.
Conclusion
In summary, in our population of ED patients, predic-
tors for influenza in older adults are similar to predic-
tors previously identified in younger adults, with the
exception that “fever” is better defined using a lower
triage temperature threshold. Current clinical definitions
of influenza do not adequately capture influenza in
older adults. Future research should focus on deter-
mining a useful clinical decision rule for influenza in
older adults.
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